Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK.
Smith C, Smith E, Chiu C, Hinton J, Perez Sepulveda B, Gordon M, Choy RKM, Hill PWS, Meiring JE, Darton TC, Carey ME, Cooke G, Gibani MM; CHANTS Consortium. Smith C, et al. Among authors: chiu c. Wellcome Open Res. 2023 Sep 21;8:111. doi: 10.12688/wellcomeopenres.19012.2. eCollection 2023. Wellcome Open Res. 2023. PMID: 37808389 Free PMC article.
Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods study.
Barker C, Collet K, Gbesemete D, Piggin M, Watson D, Pristerà P, Lawerence W, Smith E, Bahrami-Hessari M, Johnson H, Baker K, Qavi A, McGrath C, Chiu C, Read RC, Ward H. Barker C, et al. Among authors: chiu c. Wellcome Open Res. 2022 Feb 10;7:49. doi: 10.12688/wellcomeopenres.17516.1. eCollection 2022. Wellcome Open Res. 2022. PMID: 35321005 Free PMC article.
Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK.
Smith C, Smith E, Rydlova A, Varro R, Hinton JCD, Gordon MA, Choy RKM, Liu X, Pollard AJ, Chiu C, Cooke GS, Gibani MM. Smith C, et al. Among authors: chiu c. BMJ Open. 2024 Jan 10;14(1):e076477. doi: 10.1136/bmjopen-2023-076477. BMJ Open. 2024. PMID: 38199617 Free PMC article.
Human Challenge Studies with Coronaviruses Old and New.
McKendry R, Lemm NM, Papargyris L, Chiu C. McKendry R, et al. Among authors: chiu c. Curr Top Microbiol Immunol. 2022 Feb 19. doi: 10.1007/82_2021_247. Online ahead of print. Curr Top Microbiol Immunol. 2022. PMID: 35181805
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.
Killingley B, Mann AJ, Kalinova M, Boyers A, Goonawardane N, Zhou J, Lindsell K, Hare SS, Brown J, Frise R, Smith E, Hopkins C, Noulin N, Löndt B, Wilkinson T, Harden S, McShane H, Baillet M, Gilbert A, Jacobs M, Charman C, Mande P, Nguyen-Van-Tam JS, Semple MG, Read RC, Ferguson NM, Openshaw PJ, Rapeport G, Barclay WS, Catchpole AP, Chiu C. Killingley B, et al. Among authors: chiu c. Nat Med. 2022 May;28(5):1031-1041. doi: 10.1038/s41591-022-01780-9. Epub 2022 Mar 31. Nat Med. 2022. PMID: 35361992 Clinical Trial.
Controlled Human Infection Challenge Studies with RSV.
Dayananda P, Chiu C, Openshaw P. Dayananda P, et al. Among authors: chiu c. Curr Top Microbiol Immunol. 2022 Jun 16. doi: 10.1007/82_2022_257. Online ahead of print. Curr Top Microbiol Immunol. 2022. PMID: 35704096
5,460 results